Drug General Information
Drug ID
D0E4EP
Former ID
DIB010284
Drug Name
Oncolysin M
Synonyms
Anti-CD33-bR; Anti-My9-bR
Indication Leukemia [ICD9: 208.9; ICD10:C90-C95] Discontinued in Phase 1 [545607]
Company
Dana-Farber Cancer Institute Inc
CAS Number
CAS 339532-30-8
Target and Pathway
Target(s) Myeloid cell surface antigen CD33 Target Info Modulator [550922]
KEGG Pathway Hematopoietic cell lineage
Reactome Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
References
Ref 545607Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003885)
Ref 550922US patent application no. 6,926,898, Albumin fusion proteins.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.